Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study


Taher A. T. , Porter J. B. , Viprakasit V., Kattamis A., Chuncharunee S., Sutcharitchan P., ...More

53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, California, United States Of America, 10 - 13 December 2011, vol.118, pp.412-413 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 118
  • City: California
  • Country: United States Of America
  • Page Numbers: pp.412-413